Acute ulcerative colitis in a patient given rofecoxib who took aspirin as self-medication;Colite aiguë hémorragique chez une malade traitée par rofécoxib associé à une auto-médication par aspirine

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 5, 2003, Pages 511-513

  Charachon, Antoine ^a   Petit, Thomas ^a   Lamarque, Dominique ^a   Soulé, Jean Claude ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; ROFECOXIB;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; ENTERITIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINE ULCER; POSTOPERATIVE PAIN; ULCERATIVE COLITIS;

ABDOMINAL PAIN; ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; ASPIRIN; BIOPSY; COLITIS, ULCERATIVE; DRUG SYNERGISM; FEMALE; HUMANS; LACTONES; MIDDLE AGED; SCIATICA; SELF MEDICATION; SULFONES;

EID: 0038002909     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520-8.
2. Gower-Rousseau C, Grandbastien B, Colombel JF, Cortot A. Incidences des maladies inflammatoires chroniques de l'intestin en France: le tableau s'enrichit. Gastroenterol Clin Biol 1997;21:481-2.
3. Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 2002;123:1527-42.
4. Beaugerie L. Toxicité intestinale des médicaments (estomac et duodénum exclus). Encycl Méd Chir (Elsevier, Paris), Gastroentérologie, 9-100-A-15, 1996, 11 p.
5. Davies NM, Can PD. Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 1995;38:1311-21.
6. Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal anti-inflammatory drugs. Arch Intem Med 1992;152:625-32.
7. Kurahara K, Matsumoto T, Lida M, Honda K, Yao T, Fujishima M. Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations. Am J Gastroenterol 2001;96:473-80.
8. Puspok A, Kiener HP, Oberhuber G. Clinical, endoscopic and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum 2000;43:685-91.
9. Lee FD. Drug related pathological lesions of the intestinal tract. Histopathology 1994;25:303-8.
10. Petit A, Guédon C, Duhamel C, Lerebours E, Colin R. Colites ischémiques «ambulatoires». Aspects cliniques et étiologiques de 88 cas. Gastroenterol Clin Biol 1990;14:739-43.
11. Goere D, Brocheriou-Spelle I, Baron-Josselin V, Salmeron M, Houdart R. Colite aiguë grave secondaire à la prise d'aspirine. Gastroenterol Clin Biol 1999;23:686-7.
12. Hochain P, Capet C, Colin R. Complications digestives de l'aspirine. Rev Med Interne 2000;21(suppl 1):50-9.
13. Uribe A, Johansson C, Slezak P, Rubio C. Ulcerations of the colon associated with naproxen and acetylsalicylic acid treatment. Gastrointest Endosc 1986;32:242-3.
14. Fitzgerald AG, Patrono C. The coxibs selective inhibitors of cyclooxygenase-2. N Engl J Med 2001;345:433-42.
15. Cuzzocrea S, Mazzon E, Serraino I, Dugo L, Centorrino T, Ciccolo A, et al. Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats. Eur J Pharmacol 2001;431:91-102.
16. Reuter BK, Asfaha S, Buret A, Sharkey KA, Wallace JL. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 1996;98:2076-85.
17. Gomet JM, Hassani Z, Modigliani R, Lemann M. Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib. Am J Gastroenterol 2002;97:3209-10.
18. Freitas J, Farricha V, Nascimento I, Borralho P, Parames A. Rofecoxib: a possible cause of acute colitis. J Clin Gastroenterol 2002;34:451-3.
19. Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vargas R, Schnitzer TJ, et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003;124:288-92.